The New York Times – Business:
The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.
Author: RSS Feed
This post first appeared in The New York Times – Business. Read the original article.